6.25

16.39% 0.88

After Hours: 6.08 -0.17 -2.72%

Aurora Cannabis Inc. (ACB)

Overview News Price History Option Chain Why ACB Down? Discussions Forecast Stock Split

Aurora Cannabis Inc. stock is traded at $6.25, with a volume of 21.09M. It is up +16.39% in the last 24 hours and up +34.12% over the past month. Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Previous Close:

$5.37

Open:

$5.28

24h Volume:

21.09M

Relative Volume:

9.51

Market Cap:

$343.03M

Revenue:

$195.82M

Net Income/Loss:

$-88.78M

P/E Ratio:

-2.4911

EPS:

-2.5089

Net Cash Flow:

$-88.86M

1W Performance:

+63.61%

1M Performance:

+34.12%

6M Performance:

+6.29%

1Y Performance:

+56.25%

1-Day Range:

$5.26

$6.65

1-Week Range:

$3.4216

$6.65

52-Week Range:

$2.84

$9.35

Aurora Cannabis Inc. Stock (ACB) Company Profile

Name

Aurora Cannabis Inc.

Sector

Healthcare (1177)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

Address

10355 Jasper Avenue, Suite 500, Edmonton, AB

Employee

Twitter

@Aurora_MMJ

Next Earnings Date

2024-12-06

Latest SEC Filings

ACB's Discussions on Twitter

Compare ACB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACB Aurora Cannabis Inc.	6.25	343.03M	195.82M	-88.78M	-88.86M	-2.5089
ZTS Zoetis Inc	174.12	78.56B	9.15B	2.43B	2.31B	5.32
TAK Takeda Pharmaceutical Co Adr	13.61	43.15B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	9.51	43.00B	14.26B	1.55B	0	0.3383
TEVA Teva Pharmaceutical Industries Ltd Adr	17.29	19.59B	16.54B	-1.64B	749.00M	-1.45
NBIX Neurocrine Biosciences Inc	150.51	15.24B	2.24B	385.90M	440.10M	3.73

Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-11-24	Initiated	TD Cowen	Buy
Feb-09-24	Upgrade	Canaccord Genuity	Hold → Buy
Sep-21-22	Upgrade	Canaccord Genuity	Sell → Hold
Jun-24-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jun-06-22	Upgrade	Stifel	Sell → Hold
Sep-28-21	Upgrade	MKM Partners	Sell → Neutral
Sep-03-21	Upgrade	Jefferies	Underperform → Hold
May-14-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
May-14-21	Downgrade	Canaccord Genuity	Hold → Sell
May-11-21	Downgrade	CIBC	Neutral → Sector Underperform
Apr-28-21	Resumed	BofA Securities	Neutral
Feb-12-21	Downgrade	Desjardins	Hold → Sell
Feb-12-21	Downgrade	MKM Partners	Neutral → Sell
Feb-12-21	Downgrade	Needham	Hold → Underperform
Dec-18-20	Downgrade	BMO Capital Markets	Market Perform → Underperform
Nov-16-20	Downgrade	Jefferies	Hold → Underperform
Nov-11-20	Downgrade	Stifel	Hold → Sell
Oct-27-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-21-20	Upgrade	Jefferies	Underperform → Hold
Sep-08-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-24-20	Upgrade	Stifel	Sell → Hold
May-22-20	Downgrade	Jefferies	Hold → Underperform
May-15-20	Upgrade	Piper Sandler	Underweight → Neutral
Feb-27-20	Downgrade	Bryan Garnier	Neutral → Sell
Feb-25-20	Initiated	Needham	Hold
Feb-24-20	Downgrade	Cowen	Outperform → Market Perform
Feb-14-20	Upgrade	MKM Partners	Sell → Neutral
Feb-07-20	Downgrade	Canaccord Genuity	Speculative Buy → Hold
Jan-10-20	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-10-20	Downgrade	Piper Sandler	Overweight → Neutral
Dec-23-19	Downgrade	Jefferies	Buy → Hold
Nov-15-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Sep-24-19	Initiated	CIBC	Neutral

View All

Aurora Cannabis Inc. Stock (ACB) Latest News

Feb 06, 2025

Aurora Cannabis Secures Strategic $27 Million Supply Agreement with SNDL - TipRanks

Feb 06, 2025

Aurora Cannabis Secures Major Premium Cannabis Supply Agreement: Full Details Inside - StockTitan

Feb 06, 2025

Aurora Cannabis Announces Supply Agreement with SNDL - PR Newswire

Feb 06, 2025

Aurora Cannabis Shines: Earnings Call Highlights - TipRanks

Feb 06, 2025

Investors Riding the High of Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) - Investorideas.com newswire

Feb 06, 2025

Aurora sees 37% revenue growth in Q3 2025 driven by global medical cannabis expansion - MSN

Feb 06, 2025

Which Cannabis Stock Offers the Best Upside? Analysts Weigh In After ACB’s Rally - PUNE.NEWS

Feb 06, 2025

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2025 Earnings Call Transcript - Insider Monkey

Feb 06, 2025

Aurora Cannabis: Remarkable Recovery (NASDAQ:ACB) - Seeking Alpha

Feb 06, 2025

Aurora Cannabis Sees Record Growth as Medical Sales Surge 51% - PUNE.NEWS

Feb 06, 2025

Aurora Posts Record Quarter Thanks to European Medical Growth, Little Green Pharma Acquires Health House, & More From Argent Bio. - Business of Cannabis -

Feb 06, 2025

TLRY, CGC: Cannabis Stocks Rally on Aurora’s Strong Earnings - TipRanks

Feb 06, 2025

Aurora Cannabis Third Quarter 2025 Earnings: EPS: CA$0.57 (vs CA$0.51 loss in 3Q 2024) - Yahoo Finance

Feb 06, 2025